The Food and Drug Administration on Wednesday issued an emergency use authorization for Novavax's coronavirus vaccine, making it the fourth COVID vaccine available for people over 18 years old.
The big picture: The Biden administration announced this week that it had purchased over 3 million doses of Novavax's vaccine in anticipation of the FDA authorizing the vaccine.